Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation - PubMed (original) (raw)

Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation

J A Fagin et al. Endocrinology. 1988 May.

Abstract

Insulin-like growth factor-I (IGF-I) is produced in multiple tissues and is believed to exert its action in a paracrine or autocrine fashion. We have investigated the GH dependency of tissue IGF-I gene expression in rats harboring implanted somatomammotropic tumors. Circulating GH and radioimmunoassayable IGF-I levels were markedly elevated in these animals. Hepatic IGF-I messenger RNA (mRNA) transcripts were induced about 5-fold in the tumor-bearing rats relative to control animals, and about 50-fold relative to the hypophysectomized liver IGF-I mRNA. IGF-I mRNA content was also modestly induced in the heart, muscle, and kidney of the tumor-bearing animals. IGF-I mRNA transcripts of 8.0, 6.2, 3.8, 2.4, 1.3, and 1.0 kilobases were markedly stimulated in the pituitaries of the GH-tumor bearing rats relative to control pituitaries. Pituitary IGF-I mRNA induction was maximal between 2 and 6 weeks after tumor implantation, a time at which circulating GH levels were also increasing sharply. As previously reported, pituitary GH mRNA was inhibited in tumor-bearing rats. The stimulation of pituitary IGF-I gene expression in these animals, therefore, appears to be dependent on circulating, and not local, pituitary GH concentrations. These data support the GH dependency of pituitary IGF-I gene expression. IGF-I is known to decrease GH production in vitro. High circulating levels of IGF-I present in these animals may account for the observed inhibition of GH gene expression. These data raise the alternative possibility that induction of locally produced IGF-I may contribute to this phenomenon.

PubMed Disclaimer

Cited by

Differential regulation of gonadotropins and glycoprotein hormone alpha-subunit by IGF-I in anterior pituitary cells from male rats.
Pazos F, Sánchez-Franco F, Balsa J, Escalada J, Cacicedo L. Pazos F, et al. J Endocrinol Invest. 2004 Jul-Aug;27(7):670-5. doi: 10.1007/BF03347501. J Endocrinol Invest. 2004. PMID: 15505992
Pituitary Insulin: Insulin-Like Growth Factors.
Yokoyama S, Stefaneanu L, Kovacs K. Yokoyama S, et al. Endocr Pathol. 1997 Autumn;8(3):167-179. doi: 10.1007/BF02738783. Endocr Pathol. 1997. PMID: 12114720
Growth hormone. A paracrine growth factor?
Harvey S, Hull KL. Harvey S, et al. Endocrine. 1997 Dec;7(3):267-79. doi: 10.1007/BF02801319. Endocrine. 1997. PMID: 9657062 Review.
Perifusion model system to culture bovine hypothalamic slices in series with dispersed anterior pituitary cells.
Hassan HA, Merkel RA. Hassan HA, et al. In Vitro Cell Dev Biol Anim. 1994 Jul;30A(7):435-42. doi: 10.1007/BF02631311. In Vitro Cell Dev Biol Anim. 1994. PMID: 7952512
Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S. Akita S, et al. J Clin Invest. 1995 Mar;95(3):1288-98. doi: 10.1172/JCI117779. J Clin Invest. 1995. PMID: 7883977 Free PMC article.

Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation - PubMed (original) (raw)